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There is abundant evidence that neurocognitive def-
icits are present in schizophrenic patients (Aylward 
 
et al.
 
 
 

 
). A recent meta-analytical review of 
 

 
 
neurocognitive test variables concluded that schizo-
phrenia is characterized by a broadly based, moder-
ately severe (d 
 
=
 
 
 

 
.
 

 
) cognitive impairment, with 
varying degrees of deficit in all domains (Heinrichs 
& Zakzanis 
 

 
). In comparison with learning dis-
ability these deficits are mild, with around 
 

 
% of 
patients scoring in the deficit range on most tests of 
cognitive function (Green 
 

 
). This review will 
summarize some of the key findings regarding the 
relationship of cognitive deficits to the aetiology of 
schizophrenia.
 
Neurodevelopment or neurodegeneration?
 
Until the mid-
 

 
s, cognitive deficits in schizophre-
nia were thought to result from a neurodegenerative 
process that was assumed to underlie the disorder. 
However, neuropathological, epidemiological and 
neuroimaging evidence began to suggest that schizo-
phrenia may instead be associated with a relatively 
static neuropathology, arising early in life, that pre-
disposed the individual to express the disorder in 
adulthood. Schizophrenia was thus reformulated as a 
neurodevelopmental disorder (Murray & Lewis 
 

 
; 
Weinberger 
 

 
), and this model has now gained 
wide acceptance. In its current form, the neurodevel-
opmental hypothesis of schizophrenia proposes that 
genetic and early environmental factors interact to 
disrupt cortical development 
 
in utero
 
, resulting in the 
formation of abnormal connections during child-
hood. These abnormalities become manifest in ado-
lesence when they disrupt brain maturation, possibly 
through abnormalities of myelination or an excess of 
normal synaptic pruning (Takei & Murray 
 

 
). 
This neurodevelopmental insult is though to interact 
with later environmental factors leading to the onset 
of schizophrenia (Murray & Fearon 
 

 
). Although 
the precise nature of the neurodevelopmental insult 
in schizophrenia is not understood, it certainly seems 
plausible that such damage would adversely affect 
performance on cognitive tests.
The hypothesis that neurocognitive deficits in 
schizophrenia are the result of neurodevelopmental 
damage leads to three key predictions: that cognitive 
deficits will be a fundamental part of the illness (as 
opposed to a side-effect of treatment), will be present 
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before the onset of clinical symptoms, and will not 
necessarily deteriorate over time.
 
Antipsychotic drugs
 
Are cognitive deficits intrinsic to schizophrenia, 
or are they merely an unfortunate side-effect of its 
treatment? Conventional neuroleptic drugs probably 
confer a modest overall beneficial effect on neurocog-
nition (Green 
 

 
), although assessment of these 
effects may be confounded by sedation and motor 
side-effects. A further difficulty is that anticholinergic 
drugs, which are known to have a detrimental effect 
on memory in schizophrenia (Baker 
 
et al.
 
 
 

 
; 
Sweeney 
 
et al.
 
 
 

 
), are frequently co-administered 
with conventional neuroleptics in an attempt to 
reduce extrapyramidal side-effects. With modern 
‘atypical’ antipsychotics the situation is clearer, with 
two recent reviews concluding that these drugs do not 
diminish, and probably slightly enhance, cognitive 
function (Weiss 
 
et al.
 
 
 

 
; Kasper & Resinger 
 

 
).
 
Premorbid cognitive deficits
 
To establish whether cognitive deficits are present 
before the onset of illness requires the use of prospec-
tively collected, population-based data. In the past 
few years, several such studies have examined pre-
morbid cognitive function, using prospectively ascer-
tained school records and neuropsychological 
batteries (Done 
 
et al.
 
 
 

 
; Jones 
 

 
; David 
 
et al.
 
 
 

 
; Isohanni 
 
et al.
 
 
 

 
; Cannon 
 
et al.
 
 
 

 
, 
 

 
a; 
Cannon 
 
et al.
 
 
 

 
; Davidson 
 
et al
 
. 
 

 
; Fuller 
 
et al.
 
 
 

 
; Gunnell 
 
et al.
 
 
 

 
; Walker 
 
et al.
 
 
 

 
; 
reviewed in Cannon 
 
et al.
 
 
 

 
). Taken together, 
these studies provide strong evidence of cognitive and 
other developmental abnormalities in children who 
would later develop schizophrenia, in a dose–
response relationship – the worse the cognitive func-
tion, the higher the risk of schizophrenia (Cannon 
 
et al.
 
 
 

 
). There is also evidence that decline in 
cognitive functioning during childhood is associated 
with later schizophrenia. Thus Kremen and others 
(Kremen 
 
et al.
 
 
 

 
) showed that decline in IQ score 
between ages 
 

 
 and 
 

 
 years was a better predictor of 
schizophreniform disorder at age 
 

 
 than either IQ at 
age 
 

 
 or socio-economic status. Fuller and others 
examined scores on standardized cognitive tests at 
ages 
 

 
, 
 

 
 and 
 

 
 in patients who later developed 
schizophrenia. Compared with population norms, 
the preschizophrenic children had significantly lower 
scores only at age 
 

 
, and a significant drop in scores 
between ages 
 

 
 and 
 

 
 (Fuller 
 
et al.
 
 
 

 
). This 
premorbid deterioration in cognitive function was 
interpreted by the authors as suggestive of excessive 
synaptic pruning in the preschizophrenic patients.
 
Genetic or environmental?
 
The neurodevelopmental hypothesis of schizophrenia 
suggests that both genetic and environmental factors 
can lead to abnormal neurodevelopment. Are pre-
morbid cognitive deficits markers of genetic or envi-
ronmental aetiological factors? High risk studies have 
shown that the children of schizophrenic parents dis-
play abnormalities in cognitive function (Ott 
 
et al.
 
 
 

 
; Byrne 
 
et al.
 
 
 

 
), suggesting that genetic fac-
tors may be responsible. But such associations could 
be confounded by the social effects of having a psy-
chotic parent. A more rigorous approach would be to 
compare the cognitive function in childhood of unaf-
fected siblings of schizophrenic subjects with that of 
the normal population. Using this method, Cannon 
and colleagues (Cannon 
 
et al.
 
 
 

 
) showed that 
unaffected siblings of schizophrenic subjects per-
formed worse than controls at two time points, but 
nevertheless tended to outperform their affected 
siblings.
 
Early environmental insults
 
A recent meta-analysis, using only prospective popu-
lation studies, confirmed the association of low birth-
weight, asphyxia and other pregnancy and birth 
complications (PBCs) on the risk for schizophrenia 
(Cannon 
 
et al.
 
 
 

 
b). A number of PBCs have been 
found to have a negative impact on adult intelligence 
in normal samples, including antenatal hypoxia 
(Naeye & Peters 
 

 
; Seidman 
 
et al.
 
 
 

 
), low 
birth weight (Seidman 
 
et al.
 
 
 

 
; Matte 
 
et al.
 
 
 

 
) 
and neonatal malnutrition (Lucas 
 
et al.
 
 
 

 
). Could 
cognitive abnormalities in schizophrenia therefore be 
mediated by PBCs? Goldstein and colleagues (Gold-
stein 
 
et al.
 
 
 

 
) failed to find an effect of probable 
hypoxic damage on IQ at age 
 

 
 in individuals who 
were genetically predisposed to schizophrenia. Fur-
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thermore, three prospective cohort studies have dem-
onstrated little change in the relationship between 
cognitive function and schizophrenia when adjusting 
for PBCs (Cannon 
 
et al.
 
 
 

 
; Cannon 
 
et al.
 
 
 

 
a; 
Gunnell 
 
et al.
 
 
 

 
), although one found an associa-
tion between PBCs and unusual movements at 
 

 
 years (Rosso 
 
et al.
 
 
 

 
). Thus it appears that that 
cognitive deficits are more strongly associated with 
genetic than early environmental risk factors, but fur-
ther work is needed in this area.
 
Social factors
 
Cognitive function is known to correlate with a num-
ber of sociodemographic factors (Crandell & Hobson 
 

 
), and both the risk of schizophrenia and the 
likelihood of psychiatric referral may be similarly 
influenced (Verhaak 
 

 
). Social factors could medi-
ate the association between cognitive dysfunction and 
schizophrenia in two ways. The first possibility is 
confounding, whereby certain social factors predis-
pose both to poor cognitive performance and to 
schizophrenia. Possible confounders include low 
socio-economic group, urban birth and being a 
migrant. The second possibility is that social depriva-
tion leads to abnormal neurodevelopment, which in 
turn causes both cognitive impairment and schizo-
phrenia. Unfortunately there has been little work in 
this area.
Longitudinal stability of cognitive deficits 
after illness onset
Rund reviewed  longitudinal studies with a follow-
up of at least  year and found no evidence of cogni-
tive decline (Rund ). Gold and colleagues 
administered a cognitive test battery to  patients at 
illness onset and again at  years. Patients signifi-
cantly improved in most areas of cognitive function 
including performance IQ, and did not deteriorate on 
any measure other than motor speed (Gold et al. 
). Some of the improvement was accounted for 
by improvement in positive symptoms, but not by 
changes in antipsychotic or anticholinergic medica-
tion. Heaton studied  schizophrenic patients and 
 normal controls over an average of  years. Both 
the schizophrenic and control subjects improved, 
with no difference in improvement between cases and 
controls. However, the situation in elderly patients 
with schizophrenia may be different. Freidman, Har-
vey and colleagues (Friedman et al. ) followed 
up  schizophrenia patients, ranging in age 
between  and  years, for  years. Cognitive per-
formance was relatively stable before age , but 
there was marked decline in older subjects, which was 
greater than that observed in healthy controls.
Conclusion
Cognitive deficits in schizophrenia are widespread, 
and are not secondary to drug treatment. They are 
present prior to disease onset, may be partly genetic 
and are probably not simply a result of PBCs. There 
may be some widening of the gap between preschizo-
phrenics and controls during childhood, but the def-
icits appear to relatively remain stable for the initial 
years after illness onset. There may be further decline 
in older patients with schizophrenia. These findings 
are compatible with the model that cognitive deficits 
represent a marker of neurodevelopmental damage in 
schizophrenia, and may track a neurodegenerative 
process later in the course of the illness.
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